Programme
Programme subject to minor changes. Last updated 20 September.
| Time | Session |
| 09.30 - 12.00pm | Molecular Oncology Symposium This symposium will provide an overview of molecular techniques for somatic mutation testing in solid tumours (what we have now, and what is “in the pipeline”). This will be followed by consideration of current molecular testing strategies for gut and lung cancers, and a “mock” molecular tumour board using anonymised real cases to illustrate some of the applications and challenges in applying these techniques to clinical practice. Cris Print - Print Lab, University of Auckland Chris Hemmings - GI pathologist, Christchurch Hospital) Brooke Beardsley - Lead Lung Pathologist, Christchurch Hospital |
| 10.00 - 12.00pm | Cancer Trials NZ Future-proofing clinical cancer research in New Zealand at a time of major systems change Contact Sarah Benge for more info or to register: s.benge@auckland.ac.nz 021 792 791 |
| Lunch - own arrangements | |
| 1.30 - 6.00pm | RCPANZ/NZSP committee meeting, Crowne Plaza Hotel (lunch from midday) |
| 1.00 -2.30pm | Lung oncology SIG Colorectal cancer SIG Gynae cancer league SIG |
| 2.30 - 3.30pm | AstraZeneca Symposium : Mainstreaming genetic testing for ovarian cancer patients Chair: Dr Jenny Mclachlan The UK experience of mainstreaming in Ovarian Cancer patients. |
| 3.30 - 5.00pm | Gastro intestinal SIG Digital pathology SIG ctDNA SIG TME SIG |
| 5.00pm | SIG feedback session |
| Time | Session | |
| 7.45am | Mihi Whakatau | |
| 8.00am | He Akoranga Whakahoungia Tania Huria - MIHI (Maori / Indigenous Health Institute), University of Otago Myra Ruka - Waikato Hospital. Maarire Goodall Keynote Manaia Cunningham - Consultant Panel | |
| 10.00am | Morning tea | |
| 10.30am | Together into the future Richard Sullivan - King’s College London and King’s Institute of Cancer Policy | |
| 12.30pm | Lunch | |
| 1.30pm | Bruce Cain & AB Pearson lecture: Breast, basal and brain: biology-pathology-therapy These annual named lectures are given at the NZSO and NZSP meetings, respectively. | |
| 2.30pm | Integrating genomics: Lessons from gynae to pan-cancer Angela George - Royal Marsden Hospital, London | |
| 3.30pm | Afternoon tea | |
| 4.00pm | Scientists Together Analysing breast cancer in young women in Aotearoa New Zealand- The Helena McAlpine Young Women’s Breast Cancer Study Annette Lasham | |
| 4.30pm | Somatic mosaic mutations in circulating lymphocytes are associated with breast cancer risk. Ian Campbell | |
| 4.40pm | A murine immunocompetent acute myeloid leukemia (AML) model for testing immunotherapies Hui Mei Lee | |
| 4.50pm | Automated computational biomechanics workflows for improving breast cancer diagnosis and treatment Thiranja Prasad Babarenda Gamage | |
| 5.00pm | Drug re-purposing for colorectal cancer: the potency of anti-helmintic drugs mebendazole and albendazole Sarah Baird | |
| 5.10pm | Ex vivo culture of patient-derived endometrial cancer tumour Hannah van der Woude | |
| 5.30 - 7.00pm | Welcome reception amongst the posters | |
| Time | Session | |||
| 7.00am | MSD Breakfast session: Evidence and tools to support precision medicine Matthew Strother - Canterbury District Health Board Kindly sponsored by MSD | |||
| 8.45am | Pathology and oncology together A pathologist’s view: Pathologic assessment of tumour regression: it’s complicated; Chris Hemmings - Canterbury Health Laboratories and University of Otago | |||
| 10.30am | Morning tea | |||
Pharmac Emerging Researcher Award session. Science and clinical presentations | IGENZ Pathology Prize | |||
| 11.00am | Lipopolysaccharides from colorectal cancer – associated bacteria influence cytokine production in peripheral blood mononuclear cells (PBMCs) Arielle Suli | Understanding the role of H179 TP53 mutations in cancer Gaurav Gyanwali | ||
11.10am IGENZ 11.15am | Non-clear cell renal cell carcinoma: treatment pathways and outcomes at Auckland District Health Board Rachel Yuen | Role of NGS based RNA fusion panel in solving the diagnostic dilemmas in solid tumour setting Pranav Dorwal | ||
11.20am IGENZ 11.30am | Mature adipocyte modulation of breast cancer cell chemo-responsiveness Jessika Wise | Quo Vadis Androgen Receptor – What about Triple Negative Breast Cancer Alex Dubrava | ||
11.30am IGENZ 11.45am | Cancer of the nasopharynx in Aotearoa from 1994 to 2018: incidence and survival in a population-based, national registry cohort study Alice Minhinnick | |||
| 11.40am | Reprogrammed antioxidant defences in metastatic melanoma cells Therese Featherston | Poster presentations 4 minutes talking to electronic poster | ||
| 11.50am | Pan-cancer access to next-generation sequencing in Aotearoa through research: patient characteristics in MoST Olivia Perelini | Repurposing oxidative stress drugs for metastatic melanoma treatment Carol Khor | ||
| 12.00pm | Investigating the Relationship Between Ascorbate and the Differentiation of Monocytes in an Ex-Vivo Melanoma Model Ben Topham | The Great Masquerader: A Ruptured Thoracic Aortic Aneurysm With but Without Syphilis Katherine Hulme | ||
| 12.10pm | Advanced non-small cell lung cancers with KRAS variants in the Auckland region Sam Dunn | Deleterious Effect of Inhibition of Aryl Hydrocarbon Receptor Signalling on Leukaemia Stem Cells in Murine BMT Model of Acute Myeloid Leukaemia Alyona Oryshchuk | ||
| 12.20pm | Intracellular ascorbate accumulation in human glioblastoma cells in vitro Eleanor R Burgess | |||
| 12.30pm | Do immune related adverse events from immune checkpoint inhibitors confer improved survival in stage IV melanoma Eric Zheng | |||
| 12.40pm | Lunch and poster session | |||
| 1.40pm | Roche Translational Cancer Research Fellowship (2021 winners) DNA methylation panel for early detection and tracking treatment response in lung cancer patients | |||
| 2.00pm | Intro to Bridget Robinson Award Laird Cameron | |||
| 2.05pm | Presentation of award and accomplishments Bridget Robinson | |||
| 2.10pm | Awardee presentation | |||
| 2.40pm | Afternoon tea | |||
| 3.15pm | Envisioning cancer treatment services in the reformed health system Q&A | |||
| Cancer Services Delivery | ||||
| 4.20pm | Stage III Non Small Cell Lung Cancer curative intent treatment: Does post code matter? Catherine Smith | |||
| 4.30pm | Experiences of Telehealth Appointments for Oncology and Haematology Patients During NZ’s First COVID-19 Lockdown Rob McNeil | |||
| 4.40pm | National harmonisation of chemotherapy regimens in Aotearoa New Zealand Chris Jackson | |||
| 4.50pm | Session closes | |||
| 5.00 - 6.00pm | NZSO AGM Marg Currie | RCPANZ / NZSP AGM Chris Hemmings & Peter Bethwaite RCPA matters Lawrie Bott | ||
| 7.00 - 11.00pm | Conference dinner and awards at Christchurch Art Gallery Dress code is smart casual (ties not required) | |||
| PATHOLOGY DAY | |
| Time | Session |
| 8.00am | Update on cervical screening programme (NCSP) Changes coming to the NCSP in 2023: Update for histopathologists Clinical practice guidelines for the HPV primary screening era |
| 9.00am | Digital pathology in practice David Snead - PathLAKE |
| 9.45am | Digital pathology in research Gavin Harris - University of Auckland and Canterbury Health Labs |
| 10.15am | Te Aho o Te Kahu - structured pathology and data capture John Manderson |
| 10.45am | Morning tea |
| 11.15am | Academic pathologists are an endangered species: Can they be saved? Panel: |
| 12.30pm | Lunch |
| 1.30pm | Health impacts of climate change Alistair Woodward - University of Auckland |
| 2.30pm | Breast pathology - papillary lesions Sunil Lakhani - UQ Centre for Clinical Research and Pathology Queensland |
| 3.30pm | Close |